European Respiratory Society Annual Congress Barcelona 2010 September 17, 2010
Barcelona, null
Abstract by Chad Oh, Director, Clinical Development, J. Parker, G. Geba and N. Molfino on the safety profile and clinical activity of multiple subcutaneous (SC) doses of MEDI-528.
Abstract by David Gossage, Director, Clinical Development, J. Parker, G. Geba and N. Molfino titled Subcutaneous (SC) MEDI-563; Effect on blood IL-5, ECP, EDN, and eotaxin in adult asthmatics.
Abstract by Feng Jin, Scientist II, D.L. Gossage, W. White, etc. titled A multiple subcutaneous (SC) dose study of MEDI-563: a humanized anti-125RA monoclonal antibody in adult asthmatics.
Abstract by David Gossage, Director, Clinical Development, J. Parker, G. Geba and N. Molfino titled
Multiple ascending subcutaneous (SC) dose study of MEDI-563: pharmacokinetics and immune response in adult asthmatics.
Added by MedImmune on April 13, 2010